As of Dec 09
| +2.15 / +4.31%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 63.00, with a high estimate of 63.00 and a low estimate of 63.00. The median estimate represents a +21.15% increase from the last price of 52.00.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.